Use of bevacizumab (Avastin®) in KID syndrome: Case report;Uso do bevacizumab (Avastin®) na síndrome KID: Relato de caso

Arquivos Brasileiros de Oftalmologia

Volumn 73, Issue 3, 2010, Pages 285-287

  Caye, Luiza ^a   Scheid, Karin ^a   Pizzol, Melissa Manfroi Dal ^a   Freda, Roberto ^a  

^a Hospital Banco de Olhos de Porto Alegre   (Brazil)

Author keywords

Bevacizumab therapeutic use; Case reports; Corneal neovascularization drug therapy; Deafness congenital; Ectodermal dysplasia; Keratitis congenital; Syndrome

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CORNEA NEOVASCULARIZATION; HEARING IMPAIRMENT; HUMAN; ICHTHYOSIS; KERATITIS; MALE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CORNEAL NEOVASCULARIZATION; DEAFNESS; HUMANS; ICHTHYOSIS; KERATITIS; MALE; YOUNG ADULT;

EID: 78449232161     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492010000300015     Document Type: Article

References (12)

1. Skinner BA, Greist MC, Norins AL. The keratitis, ichthyosis, and deafness (KID) syndrome. Arch Dermatol. 1981;117(5):285-9.
2. Langer K, Konrad K, Wolff K. Keratitis, ichthyosis and deafness (KID)-syndrome: report of three cases and a review of the literature. Br J Dermatol. 1990;122(5):689-97.
3. Gilliam A, Williams ML. Fatal septicemia in an infant with keratitis, ichthyosis and deafness (KID) syndrome. Pediatr Dermatol. 2002;19(3):232-6.
4. Wilson GN, Squires RH Jr, Weinberg AG. Keratitis, hepatitis, ichthyosis and deafness: report and review of KID syndrome. Am J Med Genet. 1991;40(3):225-9.
5. Mazereeuw-Hautier J, Bitoun E, Chevrant-Breton J, Man SY, Bodemer C, Prins C, et al. Keratitis-ichthyosis-deafness syndrome: disease expression and espectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol. 2007; 156(5):1015-9.
6. Gómez-Faíña P, Ruiz-Viñals AT, Buil-Calvo JA, España-Albelda A, Pazos-López M, Castilla-Céspedes M. [Patient with severe corneal disease in KID syndrome]. Arch Soc Esp Oftalmol. 2006;81(4):225-7. Spanish.
7. Caceres-Rios H, Tamayo-Sanchez L, Duran-Mckinster C, de la Luz Orozco M, Ruiz-Maldonado R. Keratitis, ichthyosis, and deafness (KID syndrome): review of the literature and proposal of a new terminology. Pediatr Dermatol. 1996; 13(2):105-13. Comment in: Pediatr Dermatol. 1996;13(2):154-7. Pediatr Dermatol. 2000;17(3):244-5.
8. Messmer EM, Kenyon KR, Rittinger O, Janecke AR, Kampik A. Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome. Ophthalmology. 2005;112(2):e1-6.
9. Sonoda S, Uchino E, Sonoda KH, Yotsumoto S, Uchio E, Isashiki Y, Sakamoto T. Two patients with severe corneal disease in KID syndrome. Am J Ophthalmol. 2004;137(1):181-3.
10. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynänen M, et al. Missence mutatios in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. 2002;70(5):1341-8.
11. Alvarez A, del Castilho I, Pera A, Villamar M, Moreno-Pelayo MA, Moreno F, et al. De novo mutation in the gene encoding connexin-26 (GJB2) in a sporadic case of keratitis-ichthyosis-deafness (KID) syndrome. Am J Med Genet. 2003; 117A(1):89-91.
12. Yotsumoto S, Hashiguchi T, Chen X, Ohtake N, Tomitaka A, Akamatsu H, et al. Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndrome. Br J Dermatol. 2003;148(4):649-53.